What to know about the new weight loss pill approved by the FDA

CBS News
April 2, 2026
6 views
3 min read

Quick Insights

The Bottom Line

The FDA approved an Eli Lilly weight loss pill that doesn't require fasting, offering simpler dosing than existing GLP-1 medications.

How This Affects You

If you struggle with weight management, this pill may be easier to use than alternatives, though cost and insurance coverage will determine your actual access.

AI Summary

The FDA has approved an Eli Lilly weight loss pill that represents a significant shift in how Americans can manage their weight through medication. The drug is the second GLP-1 pill approved by regulators for weight loss, but it distinguishes itself as the first that doesn't require patients to fast or time their meals around doses, potentially improving ease of use. The approval could expand access to weight loss medication for millions of Americans who may find the simpler dosing schedule more practical than existing options. The key questions surrounding the rollout center on accessibility and cost, factors that will determine how broadly this new treatment option reaches the public.

Source Coverage Map

6 of 43 tracked sources covered this story

14% coverage
Did Not Cover (37)
ICIJ97AP World News96AP US News96AP Top News96ProPublica95+32 more

Following this story?

Get notified when new coverage appears

Other Sources Covering This Story

5 sources

Multiple outlets have reported on this story. Compare perspectives from different sources.

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

US approves new oral weight-loss pill developed by Eli Lilly
Health

US approves new oral weight-loss pill developed by Eli Lilly

<p>Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy</p><p>The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.</p><p>Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received <a href="https://www.theguardian.com/us-news/2025/dec/22/us-regulators-approve-wegovy-weight-loss-pill">approval</a> in December.</p> <a href="https://www.theguardian.com/us-news/2026/apr/01/new-weight-loss-pill-glp-1-foundayo">Continue reading...</a>

The Guardian US NewsApr 1
FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
Health

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.

PBS NewsHourApr 1
Recall impacts over 3.1 million eye drop products distributed nationwide: FDA
Health

Recall impacts over 3.1 million eye drop products distributed nationwide: FDA

The FDA said the eye drops were distributed by companies such as Kroger, Walgreens, H-E-B, Military Exchanges, and others.

The HillApr 3
Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection
Health

Massive eye drop recall reflects ongoing issues with manufacturing and FDA inspection

The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.

The ConversationApr 7
RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.
Politics

RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.

The post RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work. appeared first on ProPublica .

ProPublicaApr 3
Trump administration to rejoin offshore drilling agencies separated after 2010 Gulf oil spill - AP News
Corporate

Trump administration to rejoin offshore drilling agencies separated after 2010 Gulf oil spill - AP News

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPclpzUV93UVJQM0hGell0dFpDX19GLWtodF9pLXNCQi1vQWViX1pYMnZNYkF2d3YxSHQyVWNpckJDazFzYkVDT1k0QkN1clprT0t5VksybEwyc2laakVBTlFxcVpheW1wYVpKeWdKTGd2aHNEbHpaNEk1RjR1dVRzT3RDa2RoQ2JYS01PYk9KNlYxRDR5aGRVOXdDbktvZVh6YURmaUxDaUt4QQ?oc=5" target="_blank">Trump administration to rejoin offshore drilling agencies separated after 2010 Gulf oil spill</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsApr 3
Read Next
Over-the-counter medication abortion? These researchers say it would be safe
Health

Over-the-counter medication abortion? These researchers say it would be safe

A paper in JAMA Internal Medicine adds to the growing scientific evidence that medication abortion pills would be safe to sell over-the-counter at the pharmacy. But political opposition means that possibility may not happen anytime soon.

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources